Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1989;36(6):629-32.
doi: 10.1007/BF00637749.

Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man

Affiliations
Comparative Study

Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man

E Tanaka et al. Eur J Clin Pharmacol. 1989.

Abstract

Ten healthy male volunteers were given trimethadione (TMO) 4 mg/kg and antipyrine (AP) 500 mg alone or concomitantly to determine whether the metabolism of the drugs was mediated by the same or closely related forms of cytochrome P-450. Whether administered alone or together the clearance (CL) and half-life (t 1/2) of TMO and AP were the same, and there was a good correlation between the CL and t 1/2 of TMO and AP (alone r = 0.755 and 0.623, respectively; coadministered r = 0.771 and 0.503, respectively). Excretion of AP and its main metabolite and the clearance for production of AP metabolites after AP was administered alone were not significantly different when TMO and AP were taken together. When the two drugs were administered alone or coadministered, the correlation between the CL of TMO and the excretion of 3-hydroxymethyl-3-norantipyrine (NORA) was close (alone r = 0.734, coadministered r = 0.749). The correlation between the CL of TMO and CLm of NORA when TMO and AP were given alone or concomitantly was 0.762 and 0.772, respectively. The findings suggest that TMO metabolism and the formation of NORA in healthy subjects are mediated by a closely related form(s) of the cytochrome P-450 system.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacobiodyn. 1986 May;9(5):506-9 - PubMed
    1. Clin Pharmacokinet. 1983 Sep-Oct;8(5):371-7 - PubMed
    1. Clin Pharmacol Ther. 1987 May;41(5):522-30 - PubMed
    1. Br J Clin Pharmacol. 1987 Mar;23(3):355-7 - PubMed
    1. J Pharmacobiodyn. 1986 Mar;9(3):297-302 - PubMed

Publication types

LinkOut - more resources